LAURA M CALVI, M.D.
Osteopathic Medicine at Elmwood Ave, Rochester, NY
License number
New York 224982
Category
Osteopathic Medicine
Type
Internal Medicine
License number
New York 224982
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
601 Elmwood Ave, Rochester, NY 14642
Phone
(585) 275-2901
(585) 273-1288 (Fax)
(585) 273-1288 (Fax)
Personal information
See more information about LAURA M CALVI at radaris.comName
Address
Phone
1128 Clover St, Rochester, NY 14610
1128 Clover St, Rochester, NY 14610
601 Elmwood Ave, Rochester, NY 14620
78 Stoneleigh Ct, Rochester, NY 14618
97 Croydon Rd, Rochester, NY 14610
Organization information
See more information about LAURA M CALVI at bizstanding.comStrong Memorial Hospital - Laura M Calvi MD
601 Elmwood Ave #693, Rochester, NY 14642
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Government Contractors, Internal Medicine Physicians & Surgeons
Phone:
(585) 275-2901 (Phone)
Professional information
Laura M Calvi, Rochester NY
Specialties:
Internist
Address:
601 Elmwood Ave, Rochester, NY 14642
Education:
Harvard Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Laura M Calvi, Rochester NY
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
University of Rochester
601 Elmwood Ave, Rochester, NY 14642
601 Elmwood Ave, Rochester, NY 14642
Education:
Harvard University(1995)
Dr. Laura M Calvi, Rochester NY - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
University Rochester Med Ct-End
601 Elmwood Ave SUITE 693, Rochester 14642
(585) 275-2901 (Phone)
601 Elmwood Ave SUITE 693, Rochester 14642
(585) 275-2901 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2000, Internal Medicine, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Rochester Med Ct-End
601 Elmwood Ave SUITE 693, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
601 Elmwood Ave SUITE 693, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Education:
Medical School
Harvard Medical School
Graduated: 1994
Mass Gen Hospital
Harvard Medical School
Graduated: 1994
Mass Gen Hospital
Parathyroid Hormone Receptor Activation And Stem And Progenitor Cell Expansion
US Patent:
8309095, Nov 13, 2012
Filed:
Apr 29, 2011
Appl. No.:
13/097664
Inventors:
David T. Scadden - Weston MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 39/00, A61K 39/38, A61K 39/36
US Classification:
4241841, 424577
Abstract:
The invention relates to methods for manipulating hematopoietic stem or progenitor cells, mesenchymal stem cells, epithelial stem cells, neural stem cells and related products through activation of the PTH/PTHrP receptor in neighboring cells.
Parathyroid Hormone Receptor Activation And Stem And Progenitor Cell Expansion
US Patent:
7943136, May 17, 2011
Filed:
Nov 18, 2009
Appl. No.:
12/621325
Inventors:
David T. Scadden - Weston MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 39/00, A61K 39/38, A61K 35/26
US Classification:
4241841, 424577
Abstract:
The invention relates to methods for manipulating hematopoietic stem or progenitor cells, mesenchymal stem cells, epithelial stem cells, neural stem cells and related products through activation of the PTH/PTHrP receptor in neighboring cells.
Parathyroid Hormone Receptor Activation And Hematopoietic Progenitor Cell Expansion
US Patent:
7776334, Aug 17, 2010
Filed:
Aug 28, 2008
Appl. No.:
12/200419
Inventors:
David T. Scadden - Weston MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 39/00, A61K 39/38, A61K 35/26, C12N 5/08, C12N 5/00
US Classification:
4241841, 424577, 435372, 435375
Abstract:
The invention relates to methods for manipulating hematopoietic progenitor cells and related products. In one aspect the invention relates to the use of agents that activate a PTH/PTHrP receptor to enhance the growth and maintenance of hematopoietic progenitor cells in vivo and in vitro, to enhance mobilization of hematopoietic stem cells, to improve the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function.
Parathyroid Hormone Receptor Activation And Stem And Progenitor Cell Expansion
US Patent:
7635477, Dec 22, 2009
Filed:
Nov 8, 2005
Appl. No.:
11/268971
Inventors:
David T. Scadden - Weston MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry Kronenberg - Belmont MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry Kronenberg - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 39/00, A61K 39/38, A61K 35/26
US Classification:
4241841, 424577
Abstract:
The invention relates to methods for manipulating hematopoietic stem or progenitor cells, mesenchymal stem cells, epithelial stem cells, neural stem cells and related products through activation of the PTH/PTHrP receptor in neighboring cells.
Parathyroid Hormone Receptor Activation And Stem And Progenitor Cell Expansion
US Patent:
2013028, Oct 31, 2013
Filed:
Nov 2, 2012
Appl. No.:
13/667361
Inventors:
The General Hospital Corporation - , US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
Laura M. Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry M. Kronenberg - Belmont MA, US
International Classification:
A61K 38/29, G01N 33/74, C12N 5/0797, C12Q 1/68, C12N 5/0775, C12N 5/071
US Classification:
514 118, 435377, 435 613, 435 792, 435 721
Abstract:
The invention relates to methods for manipulating hematopoietic stem or progenitor cells, mesenchymal stem cells, epithelial stem cells, neural stem cells and related products through activation of the PTH/PTHrP receptor in neighboring cells.
Expansion Of Hematopoietic Stem Cells
US Patent:
2010032, Dec 23, 2010
Filed:
Dec 3, 2007
Appl. No.:
12/517885
Inventors:
Laura Maria Calvi - Rochester NY, US
Regis O'Keefe - Pittsford NY, US
Regis O'Keefe - Pittsford NY, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
A61K 35/12, C12N 5/0789, A61K 31/201, A61K 38/00, A61P 7/06, A61P 7/00
US Classification:
424 937, 435375, 435377, 514559, 514 206, 514 11
Abstract:
Described herein are methods, compositions and kits related to manipulating hematopoietic stem cells and more particularly to methods, compositions and kits related to increasing the number of hematopoietic stem cells in vitro and in vivo. Also described are methods, compositions and kits related to making an expanded population of hematopoietic stem cells (HSCs) and methods, compositions and kits related to using the expanded population of HSCs.
Parathyroid Hormone Receptor Activation And Hematopoietic Progenitor Cell Expansion
US Patent:
2006025, Nov 16, 2006
Filed:
Jul 25, 2003
Appl. No.:
10/521971
Inventors:
David Scadden - Weston MA, US
Laura Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry Kronenberg - Belmont MA, US
Laura Calvi - Rochester NY, US
Gregor Adams - Boston MA, US
Henry Kronenberg - Belmont MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 38/17, A61K 35/14, C12N 5/08
US Classification:
424093700, 514012000, 435372000
Abstract:
The invention relates to methods for manipulating hematopoietic progenitor cells and related products. In one aspect the invention relates to the use of agents that activate a PTH/PTHrP receptor to enhance the growth and maintenance of hematopoietic progenitor cells in vivo and in vitro, to enhance mobilization of hematopoietic stem cells, to improve the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function.